IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,910,035 | -24.2% | 246,379 | -9.8% | 0.01% | -14.3% |
Q2 2023 | $5,154,982 | +427.8% | 273,184 | +7.4% | 0.01% | +600.0% |
Q1 2023 | $976,742 | -23.8% | 254,360 | -1.6% | 0.00% | -50.0% |
Q4 2022 | $1,282,492 | +5.0% | 258,567 | +1.2% | 0.00% | 0.0% |
Q3 2022 | $1,222,000 | +4.1% | 255,574 | -2.0% | 0.00% | 0.0% |
Q2 2022 | $1,174,000 | -6.8% | 260,904 | -1.4% | 0.00% | 0.0% |
Q1 2022 | $1,259,000 | -38.9% | 264,587 | -4.8% | 0.00% | 0.0% |
Q4 2021 | $2,062,000 | +35.2% | 277,833 | +3.3% | 0.00% | 0.0% |
Q3 2021 | $1,525,000 | -14.1% | 268,915 | -0.2% | 0.00% | 0.0% |
Q2 2021 | $1,775,000 | -24.3% | 269,361 | -6.9% | 0.00% | -33.3% |
Q1 2021 | $2,344,000 | +30.1% | 289,325 | +3.5% | 0.00% | 0.0% |
Q4 2020 | $1,802,000 | +92.9% | 279,411 | +7.7% | 0.00% | +200.0% |
Q3 2020 | $934,000 | -20.9% | 259,545 | +1.1% | 0.00% | -50.0% |
Q2 2020 | $1,181,000 | +34.8% | 256,811 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $876,000 | -22.5% | 256,811 | +15.9% | 0.00% | 0.0% |
Q4 2019 | $1,131,000 | +106.8% | 221,520 | -2.0% | 0.00% | +100.0% |
Q3 2019 | $547,000 | +14.0% | 225,995 | +2.1% | 0.00% | 0.0% |
Q2 2019 | $480,000 | -20.0% | 221,402 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $600,000 | -43.9% | 221,402 | -0.6% | 0.00% | -50.0% |
Q4 2018 | $1,069,000 | -48.6% | 222,760 | +1.4% | 0.00% | -50.0% |
Q3 2018 | $2,080,000 | +9.0% | 219,618 | +12.0% | 0.00% | 0.0% |
Q2 2018 | $1,908,000 | +19.2% | 196,130 | +28.9% | 0.00% | +33.3% |
Q1 2018 | $1,600,000 | +58.6% | 152,115 | -3.4% | 0.00% | +50.0% |
Q4 2017 | $1,009,000 | -2.0% | 157,447 | +16.9% | 0.00% | 0.0% |
Q3 2017 | $1,030,000 | -2.8% | 134,658 | -9.7% | 0.00% | 0.0% |
Q2 2017 | $1,060,000 | +65.1% | 149,150 | -10.1% | 0.00% | +100.0% |
Q1 2017 | $642,000 | +81.4% | 165,950 | -4.3% | 0.00% | 0.0% |
Q4 2016 | $354,000 | -25.8% | 173,450 | -2.5% | 0.00% | 0.0% |
Q3 2016 | $477,000 | -12.3% | 177,850 | +0.7% | 0.00% | 0.0% |
Q2 2016 | $544,000 | -65.0% | 176,650 | -3.2% | 0.00% | -66.7% |
Q1 2016 | $1,556,000 | -28.2% | 182,577 | +14.3% | 0.00% | -40.0% |
Q4 2015 | $2,167,000 | +43.7% | 159,672 | +1.6% | 0.01% | +25.0% |
Q3 2015 | $1,508,000 | -33.3% | 157,135 | -0.1% | 0.00% | -20.0% |
Q2 2015 | $2,262,000 | +61.3% | 157,335 | +0.5% | 0.01% | +66.7% |
Q1 2015 | $1,402,000 | +44.4% | 156,612 | -1.6% | 0.00% | +50.0% |
Q4 2014 | $971,000 | -42.1% | 159,112 | +0.4% | 0.00% | -50.0% |
Q3 2014 | $1,678,000 | -9.6% | 158,435 | +1.1% | 0.00% | -20.0% |
Q2 2014 | $1,856,000 | -19.1% | 156,636 | +2.0% | 0.01% | -16.7% |
Q1 2014 | $2,294,000 | +2.2% | 153,636 | +0.4% | 0.01% | 0.0% |
Q4 2013 | $2,245,000 | -13.3% | 153,036 | +0.7% | 0.01% | -25.0% |
Q3 2013 | $2,588,000 | +5.9% | 152,036 | +3.2% | 0.01% | 0.0% |
Q2 2013 | $2,444,000 | +4.9% | 147,288 | +1.5% | 0.01% | 0.0% |
Q1 2013 | $2,330,000 | – | 145,110 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |